Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

NCT07428538 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis

Interventions

DRUG: Larsucosterol
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.

Collaborators

[object Object]